Form 4: Emergent BioSolutions Executive Reports Stock Transaction
SEC Form 4 Filing
Coleen Glessner, an executive at Emergent BioSolutions, reported a transaction involving the withholding of common stock to cover tax obligations.
Summary
- On June 8, 2024, Coleen Glessner, EVP, Quality & Ethics, and CPL at Emergent BioSolutions Inc., had 1,249 shares of common stock withheld to cover taxes at a price of $6.19 per share.
- Following the transaction, Glessner directly owns 163,134 shares of Emergent BioSolutions common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an executive's stock transaction for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders (officers, directors, or those holding more than 10% of the company's shares) buy or sell the company's securities. These filings provide transparency to the market regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 06/08/2024 | Date of stock transaction (tax withholding) |
| 06/11/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.